Literature DB >> 3534275

Proteinase-related broad-spectrum inhibitory activity among group-A streptococci.

W L Hynes, J R Tagg.   

Abstract

Some 10% of group-A streptococci have inhibitory activity against all nine strains (eight of them streptococci) in a set of indicators in an inhibitor-production typing (P-typing) scheme. This activity was associated with the concurrent synthesis of cell-associated proteinase by the streptococcal strain. Inhibitor production was prevented either by incubation of the test strain in conditions inimical to proteinase production, e.g., at low temperature and alkaline pH, or by addition to the medium of substances, such as glucose, iodoacetic acid, lincomycin, Congo red or trypan blue, that had an anti-proteinase effect. Inhibitory activity was not detectable in liquid cultures, but freeze-thaw extracts of cultures of group-A streptococcus strain A1013 on Gibco Columbia Agar Base (Gibco Diagnostics, Madison, WI, USA) had some inhibitory activity. The inhibitor was concentrated and partially purified, and the active agent was shown to be a high-mol.-wt cationic protein which was bactericidal for various bacteria in the logarithmic growth phase, including the homologous producer strain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534275     DOI: 10.1099/00222615-22-3-257

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes.

Authors:  Philip A Wescombe; John R Tagg
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

2.  Inverse correlation in nutritionally variant streptococci between the production of bacteriolytic activity and sensitivity to a Streptococcus pyogenes bacteriocinlike inhibitory substance.

Authors:  J R Tagg; I van de Rijn
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

Review 3.  Quorum sensing in group A Streptococcus.

Authors:  Juan Cristobal Jimenez; Michael J Federle
Journal:  Front Cell Infect Microbiol       Date:  2014-09-12       Impact factor: 5.293

4.  In vitro Inhibition of Clinical Isolates of Otitis Media Pathogens by the Probiotic Streptococcus salivarius BLIS K12.

Authors:  Tzu Yu Chen; John D F Hale; John R Tagg; Rohit Jain; Abigail L Voss; Nikki Mills; Emma J Best; Duncan S Stevenson; Philip A Bird; Tony Walls
Journal:  Probiotics Antimicrob Proteins       Date:  2020-11-12       Impact factor: 4.609

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.